<p>TransCode Therapeutics Inc. has issued an amendment to its current report, providing updated financial statements and details regarding its recent acquisition of 100% of the membership interests of ABCJ, LLC for $125,000. The amendment includes information on subsequent events, including TransCode’s commitment to provide adequate funding to meet ABCJ, LLC’s financial obligations for the next 12 months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-124226), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

RNAZ

<p>TransCode Therapeutics Files Amended 8-K on ABCJ Acquisition</p>